financetom
Business
financetom
/
Business
/
US clean energy tax subsidies to cost $825 billion over 10 years, CBO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US clean energy tax subsidies to cost $825 billion over 10 years, CBO says
Jan 17, 2025 11:21 AM

WASHINGTON (Reuters) - U.S. clean energy tax subsidies under President Joe Biden's signature Inflation Reduction Act will boost U.S. budget deficits by $825 billion over the next 10 years, Congressional Budget Office director Philip Swagel said on Friday, far above the initial $270 billion 10-year estimate.

Swagel told reporters that higher cost estimates are due in part to a different budget window, 2025-2035, compared to 2022-2031 for an initial estimate when the legislation was approved in 2022.

Costs also were higher because of subsequent rule changes that increased the uptake of electric vehicle subsidies, including a leasing provision and new tailpipe emissions standards for internal combustion cars, he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Docebo Q4 Results Beat Estimates, but Q1 Revenue Outlook Is Lower Than Expected
Docebo Q4 Results Beat Estimates, but Q1 Revenue Outlook Is Lower Than Expected
Feb 28, 2025
07:36 AM EST, 02/28/2025 (MT Newswires) -- Docebo ( DCBO ) , a learning platform provider, on Friday reported a beat in adjusted profit and revenue for the fourth quarter, while also providing a lower-than-expected revenue outlook for the first quarter of 2025. The company reported adjusted net income of US$8.7 million for the three months ended Dec. 31, compared...
Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma
Regeneron Says Linvoseltamab Recommended for EU Approval to Treat Multiple Myeloma
Feb 28, 2025
07:40 AM EST, 02/28/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a conditional marketing authorization for linvoseltamab to treat adults with relapsed and refractory multiple myeloma. The company said the recommendation specifically covers patients who have received at least three prior...
Perrigo Issues Medium-Term Financial Outlook
Perrigo Issues Medium-Term Financial Outlook
Feb 28, 2025
07:42 AM EST, 02/28/2025 (MT Newswires) -- Perrigo ( PRGO ) said Friday it expects fiscal 2025 adjusted earnings of $2.90 to $3.10 per diluted share. Analysts surveyed by FactSet expect $3.01 per share. The comapny pegs full-year organic net sales growth at 2.5% to 4.5%. Perrigo ( PRGO ) said it projects adjusted EPS compound annual growth rate of...
CompoSecure Completes Spin-Off of Resolute Holdings Into Separate Public Company
CompoSecure Completes Spin-Off of Resolute Holdings Into Separate Public Company
Feb 28, 2025
07:32 AM EST, 02/28/2025 (MT Newswires) -- CompoSecure ( CMPO ) said Friday it completed the spin-off of its subsidiary, Resolute Holdings Management (RHLD), into an independent public company. As part of the separation, the company said its shareholders received one share of Resolute Holdings for every 12 shares of CompoSecure ( CMPO ) common stock held as of February...
Copyright 2023-2026 - www.financetom.com All Rights Reserved